Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,807,733
-$154,385 QoQ
Shares Held
75,072
+7.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1,008
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 22%
Shared 0%
None 78%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Dana Investment Advisors, Inc. holds $103,613,510 across 8 Drug Manufacturers - General names. PFE ranks #6 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
35,592 | $42,690,116 | |
| 2 | ABBV |
AbbVie Inc.
|
157,662 | $39,674,065 | |
| 3 | JNJ |
Johnson & Johnson
|
34,927 | $8,870,410 | |
| 4 | MRK |
Merck & Co., Inc.
|
48,543 | $6,237,775 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
44,825 | $2,582,816 | |
| 6 | PFE |
Pfizer Inc
This page
|
75,072 | $1,807,733 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
9,640 | $1,217,917 | |
| 8 | AMGN |
Amgen Inc
|
1,471 | $532,678 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,807,733 | 75,072 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,962,118 | 69,876 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,672,284 | 67,160 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $1,702,344 | 66,811 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,498,465 | 103,072 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,505,923 | 98,892 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,646,685 | 99,762 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $3,110,094 | 107,467 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,803,064 | 100,181 | Shares | Sole | 2024-08-27 | |
| 2024-03-31 | $2,536,627 | 91,410 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,606,387 | 90,531 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $3,080,929 | 92,883 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $3,269,361 | 89,132 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $3,652,987 | 89,534 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,634,043 | 90,438 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,036,991 | 92,253 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $6,797,654 | 129,652 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $5,907,837 | 114,117 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $10,041,157 | 170,045 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $2,993,496 | 69,600 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,116,000 | 79,571 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,356,725 | 65,049 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $2,024,770 | 55,006 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,584,080 | 43,163 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $1,372,289 | 41,966 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $1,377,373 | 42,199 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||